Futura Medical plc is a pharmaceutical company which specializes in researching and developing drugs and medical devices for consumer healthcare markets, with a focus on sexual health and pain relief management. The company offers CSD500, a condom that contains an erectogenic gel, and is also developing MED3000, a topical gel for the treatment of erectile dysfunction that has completed Phase III clinical trials. Futura Medical plc also produces pain relief products, including TPR100, a topical diclofenac pain relief gel, CBD100, a topical cannabidiol formulation, and TIB200, a topical ibuprofen pain relief gel. The company was founded in 2001 and is based in Guildford, UK.